Back to search

Effect of Tamoxifen on the Enzymatic Activity of Human Cytochrome CYP2B6

Data up to Jan 2025

Published2002
Citations66
References45

Total Citations Per Year

Abstract

References (45)

Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1998 • 5,487 citations

Cytochrome P-450: Structure, Mechanism, and Biochemistry

1986 • 2,703 citations

The molecular biology of cytochrome P450s.

1988 • 1,294 citations

Endometrial Cancer in Tamoxifen-Treated Breast Cancer Patients: Findings From the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14 *

1994 • 1,259 citations

The pharmacology and clinical uses of tamoxifen

1984 • 873 citations

Mammalian Microsomal Cytochrome P450 Monooxygenase

2000 • 689 citations

Cytochrome P-450. Multiplicity of isoforms, substrates, and catalytic and regulatory mechanisms

1991 • 675 citations

Cytochrome P450

1995 • 582 citations

Risk of endometrial cancer after tamoxifen treatment of breast cancer

1994 • 574 citations

Rapid separation of low molecular weight solutes from liposomes without dilution

1978 • 444 citations

Expression of Modified Human Cytochrome P450 3A4 in Escherichia coli and Purification and Reconstitution of the Enzyme

1993 • 341 citations

Induction of covalent DNA adducts in rodents by tamoxifen.

1992 • 255 citations

The triphenylethylene drug tamoxifen is a strong liver carcinogen in the rat

1993 • 235 citations

Variable contribution of cytochromes p450 2d6, 2c9 and 3a4 to the 4-hydroxylation of tamoxifen by human liver microsomes

1997 • 221 citations

CYP2D6 catalyzes tamoxifen 4-hydroxylation in human liver.

1997 • 185 citations

Identification of the cytochrome P450 IIIA family as the enzymes involved in the N-demethylation of tamoxifen in human liver microsomes

1991 • 185 citations

The Metabolism of Tamoxifen (I.C.I. 46,474) Part I : In Laboratory Animals

1973 • 181 citations

Role of the Alanine at Position 363 of Cytochrome P450 2B2 in Influencing the NADPH- and Hydroperoxide-Supported Activities

1998 • 170 citations

THE ROLE OF CYP2B6 IN HUMAN XENOBIOTIC METABOLISM*

1999 • 169 citations

Mechanism-Based Inactivators as Probes of Cytochrome P450 Structure and Function

2001 • 128 citations

Cytochrome P-450-mediated activation and irreversible binding of the antiestrogen tamoxifen to proteins in rat and human liver: possible involvement of flavin-containing monooxygenases in tamoxifen activation.

1991 • 121 citations

Expression of Human Cytochrome P450 2B6 in Escherichia coli: Characterization of Catalytic Activity and Expression Levels in Human Liver

2000 • 111 citations

Expression of Cytochrome P450 2D6 in Escherichia coli, Purification, and Spectral and Catalytic Characterization

1995 • 104 citations

Identification of tamoxifen–DNA adducts in the endometrium of women treated with tamoxifen

2000 • 100 citations

4-Hydroxylated Metabolites of the Antiestrogens Tamoxifen and Toremifene Are Metabolized to Unusually Stable Quinone Methides

1999 • 97 citations

Identification of tamoxifen–DNA adducts in the endometrium of women treated with tamoxifen

2000 • 92 citations

Recombinant Human Cytochrome P450 1B1 Expression inEscherichia coli

1998 • 89 citations

Characterization of Cytochrome P450 Enzymes in Human Breast Tissue from Reduction Mammaplasties1

1998 • 82 citations

Synthesis and Reactivity of a Potential Carcinogenic Metabolite of Tamoxifen: 3,4-Dihydroxytamoxifen-o-quinone

1999 • 77 citations

DNA adduct formation by tamoxifen with rat and human liver microsomal activation systems

1994 • 72 citations

Studies on the metabolism and pharmacokinetics of tamoxifen in normal volunteers.

1980 • 71 citations

Identification of tamoxifen metabolites in human Hep G2 cell line, human liver homogenate, and patients on long-term therapy for breast cancer.

1995 • 69 citations

Cytochrome P-450 3A and 2D6 catalyze ortho hydroxylation of 4-hydroxytamoxifen and 3-hydroxytamoxifen (droloxifene) yielding tamoxifen catechol: involvement of catechols in covalent binding to hepatic proteins.

1999 • 68 citations

Species differences in the covalent binding of [14C]tamoxifen to liver microsomes and the forms of cytochrome P450 involved

1995 • 64 citations

Does tamoxifen cause cancer in humans?

1998 • 60 citations

Evidence that the catechol 3,4-Dihydroxytamoxifen is a proximate intermediate to the reactive species binding covalently to proteins.

1996 • 58 citations

Activation of 4-hydroxytamoxifen and the tamoxifen derivative metabolite E by uterine peroxidase to form DNA adducts: Comparison with DNA adducts formed in the uterus of Sprague-Dawley rats treated with tamoxifen

1996 • 55 citations

In Laboratory Animals

1951 • 49 citations

Characterization of Cytochrome P450 Enzymes in Human Breast Tissue from Reduction Mammaplasties

1998 • 49 citations

Microsomal and peroxidase activation of 4-hydroxy-tamoxifen to form DNA adducts: comparison with DNA adducts formed in Sprague-Dawley rats treated with tamoxifen

1995 • 49 citations

Effects of tamoxifen administration on the expression of xenobiotic metabolizing enzymes in rat liver.

1995 • 45 citations

The metabolism of tamoxifen by human cytochromes P450 is rationalized by molecular modelling of the enzyme-substrate interactions: potential importance to its proposed anti-carcinogenic/carcinogenic actions

1996 • 42 citations

Metabolism of tamoxifen by isolated rat hepatocytes: anti-estrogenic activity of tamoxifen N-oxide

1982 • 29 citations

Analysis of the catalytic specificity of cytochrome P450 enzymes through site‐directed mutagenesis

1992 • 26 citations

Multiple Oxidants in Cytochrome P450 Catalyzed Reactions Implications for Drug Metabolism

2001 • 19 citations

Cited By (0)

Loading...
Effect of Tamoxifen on the Enzymatic Activity of Human Cytochrome CYP2B6 (2002) – Journal of Pharmacology and Experimental Therapeutics | Metascience Observatory Explorer